Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

about

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response

P2860

Q58694894-06C55E1E-DC02-4E72-9E39-78B5417E269D

P2860

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Item

http://www.wikidata.org/entity/Q41158938

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Establishment of patient deriv ...... of lung cancer aggressiveness.

@en

type

Item

label

Establishment of patient deriv ...... of lung cancer aggressiveness.

@en

prefLabel

Establishment of patient deriv ...... of lung cancer aggressiveness.

@en

P1476

Establishment of patient deriv ...... of lung cancer aggressiveness

@en

P2093

Alessandra Fabbri

http://www.w3.org/2001/XMLSchema#string

Carlotta Galeone

http://www.w3.org/2001/XMLSchema#string

Giorgia Leone

http://www.w3.org/2001/XMLSchema#string

Giulia Bertolini

http://www.w3.org/2001/XMLSchema#string

Giuseppe Pelosi

http://www.w3.org/2001/XMLSchema#string

Roberto Caserini

http://www.w3.org/2001/XMLSchema#string

Ugo Pastorino

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro

Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

HER2 activating mutations are targets for colorectal cancer treatment

Prioritizing therapeutic targets using patient-derived xenograft models

Phenotypic instability of Saos-2 cells in long-term culture

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Lung cancer

A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer

P2888

s41598-017-06912-7

P304

6689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-06912-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28751748

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5532258

http://www.w3.org/2001/XMLSchema#string

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

about

P2860

P2860

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932